Daniel F. Sahm

16.9k citations
270 papers · 13.5k indexed · 2 hit papers · h-index 66
Topics
Antibiotic Resistance in Bacteria (186 papers)Antibiotics Pharmacokinetics and Efficacy (134 papers)Antibiotic Use and Resistance (101 papers)
Partner nations
United StatesCanadaJapan

In The Last Decade

Daniel F. Sahm

266 papers receiving 12.7k citations

Hit Papers

Prevalence in the United States of aac(6 ′) - Ib - cr Enc...199820262007201620061998200400600

Peers

Daniel F. Sahm
Comparison fields: 5 of 142
  • Molecular Medicine 7.7k
  • Pharmacology 4.6k
  • Epidemiology 4.4k
  • Infectious Diseases 3.1k
  • Applied Microbiology and Biotechnology 2.8k
Replace James A. Karlowsky with:
James A. Karlowsky Canada
Helen Giamarellou Greece
Robert K. Flamm United States
Daryl J. Hoban Canada
Jesús Rodríguez‐Baño Spain
Mariana Castanheira United States
John Turnidge Australia
Álvaro Pascual Spain
George G. Zhanel Canada
Rodrigo E. Mendes United States
Daniel F. Sahm relative to James A. Karlowsky Canada James A. Karlowsky's profile →
Citations per field
00.5×1.5×
James A. Karlowsky · 1×
Citations per year

Countries citing papers authored by Daniel F. Sahm

Since Specialization
Citations

This map shows the geographic impact of Daniel F. Sahm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel F. Sahm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel F. Sahm more than expected).

Fields of papers citing papers by Daniel F. Sahm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel F. Sahm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel F. Sahm. The network helps show where Daniel F. Sahm may publish in the future.

Co-authorship network of co-authors of Daniel F. Sahm

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel F. Sahm. A scholar is included among the top collaborators of Daniel F. Sahm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel F. Sahm. Daniel F. Sahm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 3
4 11
5 4
6 18
7 3
8 7
9 3
10 4
11 7
12 3
13 50
14 186
15 28
16 80
17 24
18
Prevalence in the United States of aac(6) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzymebreakdown →
631
19 34
20 79

About Daniel F. Sahm

Daniel F. Sahm is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 270 papers that have together received 13.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (186 papers), Antibiotics Pharmacokinetics and Efficacy (134 papers) and Antibiotic Use and Resistance (101 papers). The work is most often cited by research in Molecular Medicine (7.7k citations), Applied Microbiology and Biotechnology (2.8k citations) and Endocrinology (2.0k citations). Daniel F. Sahm has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include James A. Karlowsky, Clyde Thornsberry, Krystyna M. Kazmierczak, Mark E. Jones, Meredith Hackel, Deborah C. Draghi, Sibylle Lob, Michael S. Gilmore, Mark M. Huycke and George A. Jacoby. Their work appears in journals such as PLoS ONE, Cancer and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026